Agriculture and Commerce
American Music Tourism Act of 2025
The bill uses federal promotion to boost music tourism and related economic and cultural benefits for businesses and communities while risking local crowding and safety challenges and requiring federal spending that could displace other priorities.
To amend title XXVII of the Public Health Service Act, the Employee Retirement Income Security Act of 1974, and the Internal Revenue Code of 1986 to require group health plans and health insurance issuers offering group or individual health insurance coverage that provide benefits for sex-rejecting procedures to provide benefits for items and services to address the harms caused by sex-rejecting procedures and to restore healthy human form and functioning, to the greatest extent practicable.
Nuclear Advisory Committee Reform Act
The bill aims to streamline and focus advisory review of reactor licensing—reducing administrative burden and clarifying committee procedures—at the cost of less frequent independent scrutiny and potential loss of institutional expertise, which could weaken safety oversight and public trust.
Nutrition Education and Chronic Disease Prevention in Community Health Centers Act of 2026
The bill expands nutrition services and workforce capacity—with priority for underserved communities and evaluation to show value—but does so by reallocating existing ACA funds and adds administrative and sustainability costs that could shift resources away from other programs.
Affordable Innovation for the Grid Act
The bill aims to modernize grid operations and speed interconnections through AI/HPC and clearer regulatory guidance, but without funding and strong security measures it risks increased cybersecurity exposure, added costs, and potential delays between assessment and implementation.
Right to Try for Individualized Treatments Act
The bill creates a pathway for seriously ill patients to request individualized genomic investigational treatments—expanding access and adding clinician oversight—while raising substantial safety, cost, administrative, and oversight risks because these therapies are unproven and may lack coverage or standardized oversight.
PBM Act
The bill aims to lower drug prices and constrain PBM‑insurer vertical integration—benefiting patients and independent pharmacies—at the cost of substantial near‑term restructuring, increased litigation and compliance burdens, and possible service disruptions and transitional price impacts.
STOP Act
The bill sharply restricts minors' access to gender‑affirming procedures and creates federally funded detransition support and enforcement mechanisms — but it also imposes extensive liability, funding bans, and regulatory uncertainty that could reduce access to gender‑affirming care, raise costs, and chill routine medical and counseling services.
Safeguarding Women from Chemical Abortion Act
The bill sharply increases civil and criminal liability around the FDA‑approved drug mifepristone—likely reducing nationwide access and raising health, logistical, and financial burdens for patients and providers—while creating stronger private remedies for those injured and leaving existing federal obscenity laws unchanged.